MV
Manishaben Vijaybhai Gajera
About Manishaben Vijaybhai Gajera
Data last updated:
Manishaben Vijaybhai Gajera is a Director at Augxen Pharma Private Limited (since 2021). The company operates in Pharma. Augxen Pharma Private Limited reported revenue of ₹27.52 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Augxen Pharma Private Limited U33110GJ2021PTC124296 | Director | 22 Jul 2021 | 2021 | ₹27.52 Cr (FY 2025) | Active |
Board colleagues of Manishaben Vijaybhai Gajera
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hardik Bhadabhai Soliya | 09009045 | Augxen Pharma Private Limited | Director |
| Ranjanaben Patil | 09250066 | Augxen Pharma Private Limited | Director |
| Savanbhai Devchandbhai Tibadiya | 09009044 | Augxen Pharma Private Limited | Director |
| Vandanaben Maheshbhai Matholiya | 09250067 | Augxen Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manishaben Vijaybhai Gajera
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manishaben Vijaybhai Gajera
Manishaben Vijaybhai Gajera currently holds 1 directorship: Augxen Pharma Private Limited (Director, since 22 Jul 2021, revenue ₹27.52 Cr (FY 2025)).
Manishaben Vijaybhai Gajera was first appointed on 22 Jul 2021 as Director at Augxen Pharma Private Limited.
The current boards of Manishaben Vijaybhai Gajera's companies include Hardik Bhadabhai Soliya (Augxen Pharma Private Limited), Ranjanaben Patil (Augxen Pharma Private Limited), Savanbhai Devchandbhai Tibadiya (Augxen Pharma Private Limited), Vandanaben Maheshbhai Matholiya (Augxen Pharma Private Limited).